-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

Setting Realistic Goals for DEI in Hematology Trials

Symposia: Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology Program: Scientific Workshops
Friday, December 8, 2023: 3:00 PM-3:55 PM
Room 33 (San Diego Convention Center)
Moderators:
Thomas E. Witzig, MD, Mayo Clinic and Ruemu E. Birhiray, MD, Hematology Oncology of Indiana, PC
Disclosures:
Birhiray: Janssen: Consultancy, Honoraria, Speakers Bureau; Pharmacyclics: Consultancy, Honoraria, Speakers Bureau; PUMA BIOTECHNOLOGY: Consultancy, Honoraria, Speakers Bureau; LILLY: Consultancy, Honoraria, Speakers Bureau; NORVATIS: Consultancy; INCYTE: Consultancy, Honoraria, Speakers Bureau; SANOFI?GENZYME: Consultancy, Honoraria, Speakers Bureau; DOVA: Honoraria, Speakers Bureau; EXELIXIS: Consultancy, Honoraria, Speakers Bureau; BMS: Consultancy, Honoraria, Speakers Bureau; ABBVIE: Consultancy, Honoraria, Speakers Bureau; ASTRAZENECA: Consultancy, Honoraria, Speakers Bureau; BAYER: Consultancy, Honoraria, Speakers Bureau; ARRAY BIOPHARMA: Consultancy, Honoraria; GENENTECH: Consultancy, Honoraria; TAKEDA: Consultancy, Honoraria, Research Funding; DIACHII SANCHO: Consultancy, Honoraria, Research Funding; MORPHOSYS: Consultancy, Honoraria, Speakers Bureau; REGENERON: Consultancy, Honoraria, Research Funding, Speakers Bureau; KITE: Consultancy, Honoraria; GILEAD: Consultancy, Honoraria; IPSEN: Consultancy, Honoraria; STEMLINE: Consultancy, Honoraria; ADC Therapeutics: Consultancy, Honoraria; Genmab: Consultancy; CARIS: Consultancy, Honoraria; SERVIER: Honoraria, Speakers Bureau; AMGEN: Consultancy, Honoraria, Speakers Bureau; TerSera: Consultancy, Honoraria; Coherus: Consultancy, Honoraria, Speakers Bureau.
Moderator Introduction

Alan E. Mast, MD, PhD

Versiti, Milwaukee, WI; Blood Center of Wisconsin, Milwaukee, WI
Goals and Initiatives for a Representative Clinical Trial in Terms of Diversity, Equity and Inclusion: Regulatory Perspective/FDA

Nicole Gormley, MD

US Food and Drug Administration, Bethesda, MD
Goals and Initiatives for a Representative Clinical Trial in Terms of Diversity, Equity and Inclusion: Co-Operative Group Perspective

Alvaro J. Alencar, MD

Division of Hematology, Sylvester Comprehensive Cancer Center, University of Miami, Miller School of Medicine, Miami, FL
Panel Discussion
Break
See more of: Scientific Workshop on Defining Goals and Utilizing Tools for Enhancing Diversity, Equity and Inclusion (DEI) in Clinical Trials in Hematology
See more of: Scientific Workshops
<< Previous Session | Next Session >>